Article ID Journal Published Year Pages File Type
10914915 Molecular Oncology 2012 15 Pages PDF
Abstract
► There are a number of prognostic assays to predict outcome in ER+ breast cancers. ► Treatments include tamoxifen, ovarian suppression, and aromatase inhibitors. ► Therapy should be individualized with regards to risk and benefit.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Hormonal therapy in breast cancer: A model disease for the personalization of cancer care
Authors
, , ,